ASX - By Stock
|
RAP |
Re:
Is this the start of the auction?
|
|
Red bar
|
60 |
20K |
55 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
60
|
20K
|
55
|
|
ASX - By Stock
|
RAP |
Re:
COVID Cough Study
|
|
Red bar
|
5 |
2.4K |
7 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
5
|
2.4K
|
7
|
|
ASX - By Stock
|
RAP |
COVID Cough Study
|
|
Red bar
|
5 |
2.4K |
43 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
5
|
2.4K
|
43
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate Licence Agreement Clarification Announcement
|
|
Red bar
|
34 |
12K |
33 |
11/07/22 |
11/07/22 |
ASX - By Stock
|
34
|
12K
|
33
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Red bar
|
4.6K |
2.2M |
8 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
4.6K
|
2.2M
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
Red bar
|
151 |
52K |
43 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
151
|
52K
|
43
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Medgate extends licence agreement and plans to expand use
|
|
Red bar
|
151 |
52K |
54 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
151
|
52K
|
54
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Scheme Update
|
|
Red bar
|
132 |
47K |
37 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
132
|
47K
|
37
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Red bar
|
4.6K |
2.2M |
17 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
4.6K
|
2.2M
|
17
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Red bar
|
4.6K |
2.2M |
22 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
4.6K
|
2.2M
|
22
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Red bar
|
4.6K |
2.2M |
16 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
4.6K
|
2.2M
|
16
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Red bar
|
4.6K |
2.2M |
11 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
4.6K
|
2.2M
|
11
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Red bar
|
4.6K |
2.2M |
9 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
4.6K
|
2.2M
|
9
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Red bar
|
4.6K |
2.2M |
0 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
4.6K
|
2.2M
|
0
|
|
ASX - By Stock
|
RAP |
Re:
rap chart
|
|
Red bar
|
4.6K |
2.2M |
33 |
29/06/22 |
29/06/22 |
ASX - By Stock
|
4.6K
|
2.2M
|
33
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp to present at Gold Coast Investment Showcase
|
|
Red bar
|
93 |
32K |
15 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
93
|
32K
|
15
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Red bar
|
425 |
129K |
32 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
425
|
129K
|
32
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Red bar
|
425 |
129K |
50 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
425
|
129K
|
50
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Red bar
|
425 |
129K |
28 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
129K
|
28
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results from Data Confirmation Study
|
|
Red bar
|
425 |
129K |
60 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
425
|
129K
|
60
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Red bar
|
38 |
19K |
21 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
38
|
19K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Red bar
|
38 |
19K |
21 |
20/06/22 |
20/06/22 |
ASX - By Stock
|
38
|
19K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
Red bar
|
118 |
39K |
41 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
118
|
39K
|
41
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Investor Webinar
|
|
Red bar
|
118 |
39K |
71 |
17/06/22 |
17/06/22 |
ASX - By Stock
|
118
|
39K
|
71
|
|
ASX - By Stock
|
RAP |
Re:
Vote NO Pfizer offer
|
|
Red bar
|
555 |
192K |
41 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
555
|
192K
|
41
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
Red bar
|
377 |
145K |
41 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
377
|
145K
|
41
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
Red bar
|
377 |
145K |
21 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
377
|
145K
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
Red bar
|
377 |
145K |
17 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
145K
|
17
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Increased Scheme Consideration from Pfizer
|
|
Red bar
|
377 |
145K |
84 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
377
|
145K
|
84
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
Red bar
|
92 |
44K |
27 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
92
|
44K
|
27
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
Red bar
|
88 |
41K |
22 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
88
|
41K
|
22
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
Red bar
|
88 |
41K |
25 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
88
|
41K
|
25
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension Extension
|
|
Red bar
|
88 |
41K |
51 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
88
|
41K
|
51
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Suspension from Official Quotation
|
|
Red bar
|
128 |
52K |
7 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
128
|
52K
|
7
|
|
ASX - By Stock
|
RAP |
Re:
Pfizer have dangled peanuts, some RAP shareholders short sighted monkeys.
|
|
Red bar
|
36 |
13K |
18 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
36
|
13K
|
18
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Suspension from Official Quotation
|
|
Red bar
|
128 |
52K |
26 |
05/06/22 |
05/06/22 |
ASX - By Stock
|
128
|
52K
|
26
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Suspension from Official Quotation
|
|
Red bar
|
128 |
52K |
8 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
128
|
52K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Suspension from Official Quotation
|
|
Red bar
|
128 |
52K |
11 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
128
|
52K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Suspension from Official Quotation
|
|
Red bar
|
128 |
52K |
45 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
128
|
52K
|
45
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Red bar
|
98 |
46K |
58 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
98
|
46K
|
58
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Red bar
|
466 |
165K |
43 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
466
|
165K
|
43
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Red bar
|
466 |
165K |
19 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
466
|
165K
|
19
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Red bar
|
466 |
165K |
14 |
22/05/22 |
22/05/22 |
ASX - By Stock
|
466
|
165K
|
14
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Red bar
|
466 |
165K |
51 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
466
|
165K
|
51
|
|
ASX - By Stock
|
RAP |
Re:
RAP media thread.
|
|
Red bar
|
3.3K |
2.5M |
21 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
3.3K
|
2.5M
|
21
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Red bar
|
466 |
165K |
8 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
466
|
165K
|
8
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Red bar
|
466 |
165K |
10 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
466
|
165K
|
10
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Red bar
|
466 |
165K |
46 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
466
|
165K
|
46
|
|
ASX - By Stock
|
RAP |
Re:
Valuing ResApp Health
|
|
Red bar
|
466 |
165K |
52 |
10/05/22 |
10/05/22 |
ASX - By Stock
|
466
|
165K
|
52
|
|
ASX - By Stock
|
RAP |
Re:
Vote NO Pfizer offer
|
|
Red bar
|
555 |
192K |
22 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
555
|
192K
|
22
|
|